Redburn Atlantic initiated coverage of Labcorp (LH) with a Buy rating and $276 price target
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LH:
- Labcorp to offer HPV and STI self-collection solutions
- Labcorp Holdings to Announce Q1 2025 Financial Results
- Labcorp to acquire certain assets of Opko Health’s BioReference Health
- Truist remains bullish on Labcorp after ‘another nice strategic acquisition’
- Labcorp, Opko Health acquire certain assets of BioReference Health